Authors
Latest:
Analytical Strategy in the Development of BiosimilarsThe author outlines an analytical strategy for establishing similarity in biosimilar development and approval.
Latest:
Automated Concentration and Diafiltration of Multiple siRNA SamplesProject: transfer a manual concentration/diafiltration process for siRNA production.
Latest:
Standards and Best Practices to Support Trace Metal Quantitation in Cell Culture Chemically Defined Media and Hydrolysates–Review best practices for measurement of trace elements in cell culture media and hydrolysates, developed in a collaboration between USP and the BioPhorum Operations Group. Live: Tuesday, Mar. 3, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET On demand available after airing until Mar. 3, 2021 Register free
Latest:
Using Simulation to Address Capacity LimitationsModeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Latest:
Using Simulation to Address Capacity LimitationsModeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Latest:
Using Simulation to Address Capacity LimitationsModeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Latest:
Using Simulation to Address Capacity LimitationsModeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Latest:
Using Simulation to Address Capacity LimitationsModeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Latest:
Impact of cGMP on Supply ChainIncorporating regulatory requirements into the product life cycle is crucial.
Latest:
Maintaining Lab Data IntegrityThis article explores lab data integrity violation trends, as well as a sampling of the latest technologies that can help avoid them.
Latest:
Impact of Media Components on CQAs of Monoclonal AntibodiesThe authors review how media components modulate the quality of monoclonal antibody products
Latest:
Impact of Media Components on CQAs of Monoclonal AntibodiesThe authors review how media components modulate the quality of monoclonal antibody products
Latest:
Bioburden Control in the Biopharmaceutical IndustryProtecting against microbiological contaminationover the whole manufacturing process grows increasingly important.
Latest:
Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable BioreactorsA case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.
Latest:
mAb Generation Techniques Foster R&D AdvancesThe authors review methods for generating monoclonal antibodies for research and development.
Latest:
mAb Generation Techniques Foster R&D AdvancesThe authors review methods for generating monoclonal antibodies for research and development.
Latest:
mAb Generation Techniques Foster R&D AdvancesThe authors review methods for generating monoclonal antibodies for research and development.
Latest:
mAb Generation Techniques Foster R&D AdvancesThe authors review methods for generating monoclonal antibodies for research and development.
Latest:
mAb Generation Techniques Foster R&D AdvancesThe authors review methods for generating monoclonal antibodies for research and development.
Latest:
mAb Generation Techniques Foster R&D AdvancesThe authors review methods for generating monoclonal antibodies for research and development.
Latest:
Multi-Column Continuous Chromatography for Process-Intensified Capture and Polishing of Monoclonal AntibodiesDr. Grabski discusses why MCC offers significant economic advantages over traditional batch chromatography methods for purification of monoclonal antibodies. Live: Tuesday, Nov. 19, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET Register free
Latest:
Biopharmaceutical Manufacturing Using Blow–Fill–Seal TechnologyThe authors give special consideration factors affecting blow–fill–seal technology.
Latest:
Key Buying Factors for Tubing used in Biopharmaceutical ManufacturingWebinar Date/Time: Tue, May 2, 2023 11:00 AM EDT
Latest:
NIST Proposes Clarifications to Bayh-Dole March-in Rights RegulationsProposed changes to rules governing the commercialization of technologies developed with federal funding prompts significant stakeholder feedback.
